Literature DB >> 25362128

From the authors: International European Respiratory Society/American Thoracic Society guidelines on severe asthma.

Kian Fan Chung1, Sally Wenzel2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25362128     DOI： 10.1183/09031936.00120714

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

Review 1.  Targeted Therapy for Older Patients with Uncontrolled Severe Asthma: Current and Future Prospects.

Authors:  E W de Roos; J C C M In 't Veen; G-J Braunstahl; L Lahousse; G G O Brusselle
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

2.  Sialylation of MUC4β N-glycans by ST6GAL1 orchestrates human airway epithelial cell differentiation associated with type-2 inflammation.

Authors:  Xiuxia Zhou; Carol L Kinlough; Rebecca P Hughey; Mingzhu Jin; Hideki Inoue; Emily Etling; Brian D Modena; Naftali Kaminski; Eugene R Bleecker; Deborah A Meyers; Nizar N Jarjour; John B Trudeau; Fernando Holguin; Anuradha Ray; Sally E Wenzel
Journal:  JCI Insight       Date:  2019-03-07

Review 3.  Personalized health care beyond oncology: new indications for immunoassay-based companion diagnostics.

Authors:  Richard Batrla; Bruce W M Jordan
Journal:  Ann N Y Acad Sci       Date:  2015-04-09       Impact factor: 5.691

Review 4.  Development of New Therapies for Severe Asthma.

Authors:  Merritt L Fajt; Sally E Wenzel
Journal:  Allergy Asthma Immunol Res       Date:  2017-01       Impact factor: 5.764

Review 5.  Role and regulation of MKP-1 in airway inflammation.

Authors:  Seyed M Moosavi; Pavan Prabhala; Alaina J Ammit
Journal:  Respir Res       Date:  2017-08-10

6.  Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids.

Authors:  Prasad Nagakumar; Franz Puttur; Lisa G Gregory; Laura Denney; Louise Fleming; Andrew Bush; Clare M Lloyd; Sejal Saglani
Journal:  Eur Respir J       Date:  2019-08-29       Impact factor: 16.671

7.  Distinct profile of inflammatory and remodelling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction.

Authors:  Silvana Cianchetti; Cristina Cardini; Ilaria Puxeddu; Manuela Latorre; Maria Laura Bartoli; Matteo Bradicich; Federico Dente; Elena Bacci; Alessandro Celi; Pierluigi Paggiaro
Journal:  World Allergy Organ J       Date:  2019-12-09       Impact factor: 4.084

8.  Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.

Authors:  David J Jackson; John Busby; Paul E Pfeffer; Andrew Menzies-Gow; Thomas Brown; Robin Gore; Martin Doherty; Adel H Mansur; Simon Message; Robert Niven; Mitesh Patel; Liam G Heaney
Journal:  Thorax       Date:  2020-12-09       Impact factor: 9.139

9.  Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET.

Authors:  Mark C Liu; Elisabeth H Bel; Oliver Kornmann; Wendy C Moore; Norihiro Kaneko; Steven G Smith; Neil Martin; Robert G Price; Steven W Yancey; Marc Humbert
Journal:  ERJ Open Res       Date:  2022-01-10

Review 10.  The emerging role of transient receptor potential channels in chronic lung disease.

Authors:  Maria G Belvisi; Mark A Birrell
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.